6533b82dfe1ef96bd1290aa7
RESEARCH PRODUCT
Ambulatory Glucose Profile Applied to Flash Glucose Monitoring in Real Life: An Expert Opinion.
Alberto MaranSofia ToniCarla GiordanoKatherine Espositosubject
Blood Glucosemedicine.medical_specialtymultiple daily insulin injectionstype 1 diabetesEndocrinology Diabetes and MetabolismMonitoring ambulatoryBiomedical Engineeringflash glucose monitoringrate of changeMonitoring Ambulatory030209 endocrinology & metabolismBioengineeringglucose-monitoring systemMDI03 medical and health sciencesFlash (photography)0302 clinical medicineDiabetes mellitusBlood Glucose Self-MonitoringmedicineInternal MedicineIn real lifeambulatory glucose profile; diabetes; flash glucose monitoring; glucose-monitoring systems; glycemic control030212 general & internal medicineglucose-monitoring systemsIntensive care medicineambulatory glucose profileExpert TestimonyReview Articlesdiabetesbusiness.industryMedicine (all)Blood Glucose Self-MonitoringCSIImedicine.diseaseDiabetes Mellitus Type 1GlucosediabeteExpert opinioninsulin pumpAmbulatoryglucose profileglycemic controlcontinuous glucose monitoringMedical emergencybusinessdescription
The clinical benefits of real time continuous glucose monitoring (rtCGM) use have been well demonstrated in both CSII- and MDI-treated individuals in large clinical trials. However, recommendations for patient use of rtCGM in everyday life situations are lacking. This article provides guidance to clinicians and patients with type 1 diabetes (T1D) in effective use of rtCGM data, including glucose rate of change (ROC) arrows, for insulin dosing adjustments and other treatment decisions. The recommendations presented here are based on our own clinical experiences as endocrinologists, our personal experiences living with T1D using rtCGM, and findings from a recent survey of T1D patients who have successfully used rtCGM in their self-management. It is important that both clinicians and people with diabetes understand the utility and limitations of rtCGM. Maintaining a collaborative clinician-user relationship remains an important factor in safe, successful rtCGM use.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2016-01-01 | Journal of diabetes science and technology |